Sputum cytologic atypia predicts incident lung cancer: Defining latency and histologic specificity

Cancer Epidemiology Biomarkers and Prevention

Volumn 17, Issue 1, 2008, Pages 158-162

  Byers, Tim ^a,d   Wolf, Holly J ^a   Franklin, Wilbur A ^a   Braudrick, Sarah ^a   Merrick, Daniel T ^a,b   Shroyer, Kenneth R ^a   Hirsch, Fred R ^a   Zeng, Chan ^a   Barón, Anna E ^a   Bunn, Paul A ^a   Miller, York E ^a,b   Kennedy, Timothy C ^c  

^a UNIVERSITY OF COLORADO   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c Lung Cancer Institute of Colorado   (United States)

^d UNIVERSITY OF COLORADO CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOCARCINOMA; ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER RISK; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONFIDENCE INTERVAL; CYTODIAGNOSIS; DIAGNOSTIC ACCURACY; DISEASE MARKER; DISEASE SEVERITY; FEMALE; HAZARD RATIO; HISTOLOGY; HUMAN; LOGISTIC REGRESSION ANALYSIS; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; RESPIRATORY SYSTEM; RISK; SAMPLING; SMOKING; SPUTUM ANALYSIS; SQUAMOUS CELL CARCINOMA;

ADENOCARCINOMA; ADULT; AGED; CARCINOMA, SMALL CELL; CARCINOMA, SQUAMOUS CELL; COHORT STUDIES; FEMALE; HUMANS; INCIDENCE; LUNG; LUNG NEOPLASMS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SMOKING; SPUTUM;

EID: 38849179316     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-07-0436     Document Type: Article

References (19)

1. Henschke CI, Yankelevitz DF, Libby DM, et al.; International Early Lung Cancer Action Program Investigators. Survival of patients with stage I lung cancer detected on CT screening. N Engl J Med 2006;355:1763-71.
2. Mulshine JL, Sullivan DC. Clinical practice. Lung cancer screening. N Engl J Med 2005;352:2714-20.
3. Bach P, Jett J, Tockman M, Swensen S, Begg C. Computed tomography screening and lung cancer outcomes. JAMA 2007;297:995-7.
4. Flehinger BJ, Melamed MR, Zaman MB, Heelan RT, Perchick WB, Martini N. Early lung cancer detection: Results of the initial (prevalence) radiologic and cytologic screening in the Memorial Sloan-Kettering Study. Am Rev Respir Dis 1984;130:555-60.
5. Frost JK, Ball WC, Levin ML, et al. Early lung cancer detection: results of the initial (prevalence) radiologic and cytologic screening in the Johns Hopkins Study. Am Rev Respir Dis 1984;130:549-54.
6. Fontana RS, Sanderson DR., Taylor WF, et al. Early lung cancer detection: results of the initial (prevalence) radiologic and cytologic screening in the Mayo Clinic Study. Am Rev Respir Dis 1984;130:561-5.
7. Tockman M. Advances in sputum analysis for screening and early detection of lung cancer. Cancer Control 2000;7:19-24.
8. Kubik A, Parkin DM, Khlat M, Erban J, Polak J, Adamec M. Lack of benefit from semi-annual screening for cancer of the lung: follow-up report of a randomized controlled trial on a population of high-risk males in Czechoslovakia. Int J Cancer 1990;45:26-33.
9. Hirsch FR, Franklin WA, Gadzar AF, Bunn PA, Jr., Early detection of lung cancer: clinical perspectives of recent advances in biology and radiology. Clin Cancer Res 2001;7:5-22.
10. Petty TL, Tockman MS, Palcic B. Diagnosis of roentgenographically occult lung cancer by sputum cytology. Clin Chest Med 2002;23:59-64.
11. Prindiville S, Byers T, Hirsch F, et al. Sputum cytological atypia as a predictor of incident lung cancer in a cohort of heavy smokers with airflow obstruction. Cancer Epidemiol Biomarkers Prev 2003;12:987-93.
12. Marcus P, Bergstralh E, Fagerstrom R, et al. Lung cancer mortality in the Mayo Clinic Lung Project: impact of extended follow-up. J Natl Cancer Inst 2000;92:1308-15.
13. Kennedy TC, Proudfoot SP, Piantadosi S, et al. Efficacy of two sputum collection techniques in patients with air flow obstruction. Acta Cytol 1999;43:630-6.
14. Kennedy TC, Proudfoot SP, Franklin WA, et al. Cytopathological analysis of sputum in patients with airflow obstruction and significant smoking histories. Cancer Res 1996;56:4673-8.
15. Archer PG, Koprowska I, McDonald JR, Naylor B, Papanicolaou GN, Umiker WO. A study of variability in the interpretation of sputum cytology slides. Cancer Res 1966;26:2122-44.
16. Cox DR. Regression models and life table. J R Stat Soc 1972;B34:187-220.
17. Holiday DB, McLarty JW, Farley ML, et al. Sputum cytology within and across laboratories. A reliability study. Acta Cytol 1995;39:195-206.
18. Varella-Garcia M, Kittelson J, Schulte A, et al. Multi-target interphase fluorescence in situ hybridization assay increases sensitivity of sputum cytology as a predictor of lung cancer. Cancer Detect Prev 2004;28:244-51.
19. Belinsky S, Liechty K, Gentry F, et al. Promoter hypermethylation of multiple genes in sputum precedes lung cancer incidence in a high risk cohort. Cancer Res 2006;66:3338-44.